Cidara Therapeutics Statistics

Total Valuation

CDTX has a market cap or net worth of $50.87 million. The enterprise value is $27.68 million.

Market Cap	50.87M
Enterprise Value	27.68M

Important Dates

The last earnings date was Wednesday, May 15, 2024, after market close.

Earnings Date	May 15, 2024
Ex-Dividend Date	n/a

Share Statistics

CDTX has 4.56 million shares outstanding. The number of shares has decreased by -10.31% in one year.

Shares Outstanding	4.56M
Shares Change (YoY)	-10.31%
Shares Change (QoQ)	+0.24%
Owned by Insiders (%)	7.34%
Owned by Institutions (%)	29.29%
Float	3.88M

Valuation Ratios

PE Ratio	n/a
Forward PE	5.75
PS Ratio	1.12
Forward PS	3.49
PB Ratio	n/a
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	0.60
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.72

Current Ratio	0.72
Quick Ratio	0.55
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	58.82

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-58.10%
Return on Capital (ROIC)	n/a
Revenue Per Employee	$672,145
Profits Per Employee	-$528,493
Employee Count	69
Asset Turnover	0.74
Inventory Turnover	n/a

Taxes

In the past 12 months, CDTX has paid $443,000 in taxes.

Income Tax	443,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -58.48% in the last 52 weeks. The beta is 1.11, so CDTX's price volatility has been higher than the market average.

Beta (1Y)	1.11
52-Week Price Change	-58.48%
50-Day Moving Average	14.76
200-Day Moving Average	15.86
Relative Strength Index (RSI)	38.03
Average Volume (30 Days)	64,274

Short Selling Information

The latest short interest is 83,705, so 1.83% of the outstanding shares have been sold short.

Short Interest	83,705
Short Previous Month	163,367
Short % of Shares Out	1.83%
Short % of Float	2.16%
Short Ratio (days to cover)	0.71

Income Statement

In the last 12 months, CDTX had revenue of $46.38 million and -$36.47 million in losses. Loss per share was -$8.08.

Revenue	46.38M
Gross Profit	43.29M
Operating Income	-38.15M
Pretax Income	-36.02M
Net Income	-36.47M
EBITDA	-35.16M
EBIT	-36.65M
Loss Per Share	-$8.08

Full Income Statement

Balance Sheet

The company has $29.02 million in cash and $4.65 million in debt, giving a net cash position of $24.37 million or $5.34 per share.

Cash & Cash Equivalents	29.02M
Total Debt	4.65M
Net Cash	24.37M
Net Cash Per Share	$5.34
Equity / Book Value	-17.78M
Book Value Per Share	-3.90
Working Capital	-18.59M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$18.18 million and capital expenditures -$434,000, giving a free cash flow of -$18.61 million.

Operating Cash Flow	-18.18M
Capital Expenditures	-434,000
Free Cash Flow	-18.61M
FCF Per Share	-$4.10

Full Cash Flow Statement

Margins

Gross margin is 93.35%, with operating and profit margins of -82.26% and -78.63%.

Gross Margin	93.35%
Operating Margin	-82.26%
Pretax Margin	-77.67%
Profit Margin	-78.63%
EBITDA Margin	-75.81%
EBIT Margin	-79.02%
FCF Margin	-40.13%

Dividends & Yields

CDTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	10.31%
Shareholder Yield	10.31%
Earnings Yield	-70.06%
FCF Yield	-35.76%

Analyst Forecast

The average price target for CDTX is $61.67, which is 451.96% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$61.67
Price Target Difference	451.96%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	12.28%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on April 24, 2024. It was a reverse split with a ratio of 1:20.

Last Split Date	Apr 24, 2024
Split Type	Reverse
Split Ratio	1:20

Scores

CDTX has an Altman Z-Score of -13.39 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-13.39
Piotroski F-Score	1